LU70985A1 - - Google Patents

Info

Publication number
LU70985A1
LU70985A1 LU70985A LU70985A LU70985A1 LU 70985 A1 LU70985 A1 LU 70985A1 LU 70985 A LU70985 A LU 70985A LU 70985 A LU70985 A LU 70985A LU 70985 A1 LU70985 A1 LU 70985A1
Authority
LU
Luxembourg
Application number
LU70985A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of LU70985A1 publication Critical patent/LU70985A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J63/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • C07J63/008Expansion of ring D by one atom, e.g. D homo steroids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
LU70985A 1973-09-26 1974-09-24 LU70985A1 (enExample)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19732349024 DE2349024A1 (de) 1973-09-26 1973-09-26 6beta,7beta-epoxy-1alpha,2alphamethylen-d-homo-4-pregnen-3,20-dione

Publications (1)

Publication Number Publication Date
LU70985A1 true LU70985A1 (enExample) 1975-03-06

Family

ID=5894080

Family Applications (1)

Application Number Title Priority Date Filing Date
LU70985A LU70985A1 (enExample) 1973-09-26 1974-09-24

Country Status (16)

Country Link
US (1) US3965128A (enExample)
JP (1) JPS5059362A (enExample)
AR (1) AR202946A1 (enExample)
AU (1) AU7374074A (enExample)
BE (1) BE820381A (enExample)
DD (1) DD114599A5 (enExample)
DE (1) DE2349024A1 (enExample)
DK (1) DK507974A (enExample)
FI (1) FI280574A7 (enExample)
FR (1) FR2244492A1 (enExample)
IL (1) IL45629A0 (enExample)
LU (1) LU70985A1 (enExample)
NL (1) NL7412747A (enExample)
NO (1) NO743449L (enExample)
SE (1) SE7412058L (enExample)
ZA (1) ZA746131B (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1399199A (en) * 1997-11-14 1999-06-07 Merck & Co., Inc. Immunosuppressant tetracyclic triterpenes
US6022890A (en) * 1997-11-14 2000-02-08 Merck & Co., Inc. Immunosuppressant tetracyclic triterpenes
US8093273B2 (en) 2004-10-20 2012-01-10 Resverlogix Corp. Flavanoids and isoflavanoids for the prevention and treatment of cardiovascular diseases
EP1909788A2 (en) * 2005-07-29 2008-04-16 Resverlogix Corp. Pharmaceutical compositions for the prevention and treatment of complex diseases and their delivery by insertable medical devices
US8053440B2 (en) 2007-02-01 2011-11-08 Resverlogix Corporation Compounds for the prevention and treatment of cardiovascular diseases
ES2532402T3 (es) 2008-06-26 2015-03-26 Resverlogix Corporation Métodos de preparación de derivados de quinazolinona
WO2010079431A2 (en) 2009-01-08 2010-07-15 Resverlogix Corp. Compounds for the prevention and treatment of cardiovascular disease
CA2992231C (en) 2009-03-18 2022-03-29 Resverlogix Corp. Phenyl-quinazolin-4(3h)-one and phenyl-pyrido[2,3-d]pyrimidin-4(3h)-one derivatives and compositions thereof useful as anti-inflammatory agents
ES2706651T3 (es) 2009-04-22 2019-03-29 Resverlogix Corp Nuevos agentes antiinflamatorios
SI2773354T1 (sl) 2011-11-01 2019-08-30 Resverlogix Corp. Peroralne formulacije s takojšnjim sproščanjem za substituirane kinazolinone
US9073878B2 (en) 2012-11-21 2015-07-07 Zenith Epigenetics Corp. Cyclic amines as bromodomain inhibitors
US9765039B2 (en) 2012-11-21 2017-09-19 Zenith Epigenetics Ltd. Biaryl derivatives as bromodomain inhibitors
CA2895905A1 (en) 2012-12-21 2014-06-26 Zenith Epigenetics Corp. Novel heterocyclic compounds as bromodomain inhibitors
CN107530356A (zh) 2015-03-13 2018-01-02 雷斯韦洛吉克斯公司 用于治疗补体相关疾病之组合物及治疗方法

Also Published As

Publication number Publication date
FI280574A7 (enExample) 1975-03-27
AR202946A1 (es) 1975-07-31
DE2349024A1 (de) 1975-04-10
NL7412747A (nl) 1975-04-01
NO743449L (enExample) 1975-04-28
FR2244492A1 (enExample) 1975-04-18
DD114599A5 (enExample) 1975-08-12
AU7374074A (en) 1976-04-01
US3965128A (en) 1976-06-22
DK507974A (enExample) 1975-06-09
ZA746131B (en) 1975-09-24
IL45629A0 (en) 1974-11-29
JPS5059362A (enExample) 1975-05-22
SE7412058L (enExample) 1975-03-27
BE820381A (fr) 1975-03-26

Similar Documents

Publication Publication Date Title
AR201235Q (enExample)
AR201231Q (enExample)
FR2244492A1 (enExample)
AR201229Q (enExample)
AR199451A1 (enExample)
AR195948A1 (enExample)
AR193950A1 (enExample)
AR201432A1 (enExample)
AR196382A1 (enExample)
AR197627A1 (enExample)
AR200256A1 (enExample)
AR195311A1 (enExample)
AU477824B2 (enExample)
AR200885A1 (enExample)
AR196123Q (enExample)
AR196212Q (enExample)
AU5288973A (enExample)
CH560069A5 (enExample)
AU479521A (enExample)
CH565264A5 (enExample)
CH560998A5 (enExample)
AU479420A (enExample)
AU479405A (enExample)
CH1501974A4 (enExample)
BG22494A1 (enExample)